Methods
Forty patients with STEMI were divided into two groups (A and B): Group A (20 patients) received IC bolus of tirofiban (25 µg/kg) plus MT, while group B patients underwent pPCI with an intravenous (IV) bolus of tirofiban (25 µg/kg) and no MT. Subsequently, both groups received IV tirofiban infusion for the next 16 h (0.15 µg/kg/min). Both groups had similar baseline clinical characteristics and door to balloon time.
Methods
Forty patients with STEMI were divided into two groups (A and B): Group A (20 patients) received IC bolus of tirofiban (25 µg/kg) plus MT, while group B patients underwent pPCI with an intravenous (IV) bolus of tirofiban (25 µg/kg) and no MT. Subsequently, both groups received IV tirofiban infusion for the next 16 h (0.15 µg/kg/min). Both groups had similar baseline clinical characteristics and door to balloon time.